Published 12 hours ago • loading... • Updated 12 hours ago

Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results

Summary by The Record

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing

3 Articles

All

Left

Center

Right

+2 Reposted by 2 other sources

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing

16 hours ago·Waterloo, Canada

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources3

Leaning Left3Leaning Right0Center0Last Updated7 hours agoBias Distribution

100% Left

100% Left

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

The Record broke the news in Waterloo, Canada 16 hours ago on Wednesday, June 25, 2025.

Sources are mostly out of (0)